Home › Attention Deficit Hyperactivity Disorder › New York
Attention Deficit Hyperactivity Disorder clinical trials in New York
6 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in New York.
Cities in New York
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Staten Island
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 6, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Staten Island
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Nov 6, 2026 · NCT07717892A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- The Medical Research Network, LLC, New York
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07759154AWARE: Management of ADHD in Autism Spectrum Disorder
- University of Rochester, Rochester
RecruitingPhase 4
Ages 4 to 17 · All sexes · Updated Oct 22, 2026 · NCT05916339An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
- NYU Langone Health, New York
RecruitingPhase 4
Ages 18 to 60 · All sexes · Updated Apr 29, 2026 · NCT06577779A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
- Icahn School of Medicine at Mount Sinai, New York
RecruitingHealthy volunteers welcome
Ages 6 to 17 · All sexes · Updated Dec 11, 2024 · NCT06728969From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.